Skip to main content
3 Biotech logoLink to 3 Biotech
. 2012 Sep 18;3(3):173–185. doi: 10.1007/s13205-012-0089-x

Alpinia: the gold mine of future therapeutics

S Ghosh 1, L Rangan 1,
PMCID: PMC3646104  PMID: 28324376

Abstract

Since prehistoric era, plant-derived drugs were much preferred due to their less side effects than drugs of synthetic origin. Bioassay-guided selection of active fraction of a plant extract and further isolation and characterization of the pure bioactive compounds are in practice in both academic and industrial research. Zingiberaceae, a medicinally important, ornamental, monocotyledonous family has potential members in the tribe Alpinieae, among which the genus Alpinia is studied under this current review due to its wide range of biomedical applications. The members in the genus possess many bioactive compounds against harmful microbes to deadly diseases like cancer by regulating the different signalling pathway systems. Several compounds have been discovered and found to deliver diversified biological efficacy either in vitro or in vivo against a range of diseases. The chemical profiling of the genus and investigation of crude essential oils and individual bioactive compounds towards the therapeutic importance in various disciplines have been documented in the current review.

Keywords: Alpinia, Anticancer, Antioxidant, Bioactive compounds, Essential oil, Pharmacological

Introduction

Plant-derived drug research has become more promising in recent years and also a better alternative for synthetic medicine and therapeutics in spite of many challenges (Vanwyk and Wink 2009). The bioactive natural compounds isolated from various parts of a plant are the key research thrust for a chemist, biologist, pharmacist, and medical professionals to tease and tap the potential of the so-called the ‘wonder’ molecules. In spite of great technological advancement in the field of applied science, medical treatments are still in its infancy when the treatment against the deadly diseases like cancer is considered. In many cases, it has been found that treatment of such diseases with the chemosynthetic drugs shows frequent side effects, toxicity, severe mental and physical abnormalities, not acceptable to the patient and to their families. Hence, the conservative mode of medical treatments and synthetic drugs available ‘off the shelf’ appears to be a serious concern.

Nearly, 21,000 plants have been listed by the World Health Organization (WHO), which are in use for diverse medicinal purposes around the world. Being the largest producer of medicinal herbs, India is known as the botanical garden of the world catering to the needs for herbal medicines (Seth and Sharma 2004). The WHO report revealed that around 80 % of world population depends on the traditional medicines, largely on plant-derived drugs towards their healthcare, among which 30 % of currently used therapeutics are from natural resources alone. Owing to the increasing cultural acceptability and significantly lower side effects, nearly 75–80 % of the whole population in the developing countries mostly prefers the herbal treatment for primary health care (Ghasi et al. 2000).

Ethnopharmacogological knowledge towards the scientific investigation of medicinally important plants augments the prospects of alternative medicine and therapeutic values. The ethnomedical practices of the tribal communities of North East India were critically studied and documented for the Zingiberaceae family towards their future pharmacological diagnostics (Tushar et al. 2010). This important family is distributed worldwide with about 50 genera and 1,300 diverse species mainly concentrating in South and Southeast Asia (Wu and Larson 2000). In India, about 22 genera and 178 species have been reported from North Eastern and peninsular region (Jain and Prakash 1995), whereas North East region alone harbours 19 genera and close to about 88 diverse species (Prakash and Mehrotra 1995). Latin and species description in many cases are in doubtful identity.

The largest genus of the family Zingiberaceae, Alpinia, was classified by Charles Plumier, the famous French botanist and named after Prospero Alpino, the well-known Italian botanist of sixteenth century. The genus, Alpinia belongs to the flowering plants group (angiosperms); as per the Angiosperm Phylogeny Group II (APG II) system, it comes under the umbrella of monocotyledonous plants (Angiosperm Phylogeny Group 2003), belonging to the order Zingiberales, subfamily Alpinioideae and tribe Alpinieae. The genus includes 230–250 species distributed throughout tropical and subtropical climates of Asia and the Pacific. DNA-based studies showed the genus as polyphyletic represented by six clades scattered across the tribe Alpinieae (Kress et al. 2005).

Majority of the members of the genus produces attractive inflorescence, possesses aromatic aerial and underground parts generally subjected to different fractionation process for the extraction of essential oils, aqueous extract and bioactive components. Various parts of this plant have significant potential to yield bioactive components towards the development of future therapeutics (Fig. 1). The essential oil extracted from different parts of the plant contains diverse natural compounds having multiple medicinal properties. Because of its multipurpose utility, the genus Alpinia demands much attention from the researchers towards the development of potential therapeutics against various diseases like cancer, diabetes, ulcer and many neural disorders. Several research and reviews shows the importance and medical application of potential bioactive compounds isolated from different species of the genus and further research is continuing to unveil the mechanism of action of the natural bioactive compounds in regulating the disease progression and cure. The current aim of this study is to highlight the exhaustive pharmacological information and promising therapeutic uses of the genus Alpinia.

Fig. 1.

Fig. 1

Different plant parts of A. nigra used to extract bioactive compounds. a Alternate phyllotaxy of plants, inset depicts the stolon type of rhizome; b racemose type of inflorescence, inset shows single flower, c developing fruit cluster, inset shows mature seeds, d pulpy dehusked fruit (trilocular), e locules and mature seeds, f different stages of fruit maturity and g longitudinal and cross-sectional view of the immature fruit

Isolation and characterization of natural bioactive compound (phyotochemistry)

The members of the genus Alpinia have complex chemical profiles and possess diverse flavonoids and are being considered as chemosystematic markers for the key identification and order classification (Pugialli et al. 1993). The flavonoids, in general, are known to be responsible for yellow pigmentation in plant tissues, and are potential source of antioxidants, many of which have anticancerous activities due to the presence of functional keto (C=O) or aldehyde (–CHO) groups (Williams et al. 2004). The aqueous and organic solvent extract harbours many bioactive compounds and their natural derivatives which differ from species to species and also plant parts used (rhizomes, stems, leaves, flowers, seeds and fruits) for isolation (Table 1).

Table 1.

List of prospective pharmacologically important bioactive compounds isolated from different species of Alpinia

Species name Plant parts used Structure and name of the compounds Bioactivities References
A. galanga Rhizome graphic file with name 13205_2012_89_Figa_HTML.gif Antifungal Janssen and Scheffer (1985)
A. mutica Rhizome graphic file with name 13205_2012_89_Figb_HTML.gif Anticancer Malek et al. (2011)
A. katsumadai Seeds graphic file with name 13205_2012_89_Figc_HTML.gif Anticancer Hua et al. (2009)
A. galanga Rhizome graphic file with name 13205_2012_89_Figd_HTML.gif Treatment against osteoarthritis Phitak et al. (2009)
A. oxyphylla Kernels graphic file with name 13205_2012_89_Fige_HTML.gif Neuroprotective activity An et al. (2008)
A. conchigera graphic file with name 13205_2012_89_Figf_HTML.gif Inhibitor of NF-κB activation Lee et al. (2006)
A. officinarum Rhizome graphic file with name 13205_2012_89_Figg_HTML.gif Antiinflammatory Yadav et al. (2003)
A. blepharocalyx Seeds graphic file with name 13205_2012_89_Figh_HTML.gif Antiplatelet
A. speciosa Rhizome graphic file with name 13205_2012_89_Figi_HTML.gif Antioxidant Masuda et al. (2000)
A. zerumbet Leaves graphic file with name 13205_2012_89_Figj_HTML.gif HIV-1 integrase and neuraminidase inhibitors Upadhyay et al. (2011)
A. galanga Rhizome graphic file with name 13205_2012_89_Figk_HTML.gif Antileishmanial Kaur et al. (2010)
A. ligulata and A. nieuwenhuizii Rhizome graphic file with name 13205_2012_89_Figl_HTML.gif Antimicrobial Yusoff et al. (2011)

Therefore, before exploitation of these natural compounds for diverse biological activities, isolation and characterization for each of them need to be done primarily by different spectral and analytical techniques. The isolation, chemical and molecular characterization of natural compounds has been done by standard bioanalytical techniques like preparative thin layer chromatography (pTLC), column chromatography (CC), high performance liquid chromatography (HPLC), ultraviolet (UV) spectral analysis, fourier transform infrared spectroscopy (FTIR), 13C and 1H nuclear magnetic resonance (NMR) and mass spectroscopy (MS). Till date, several bioactive compounds have been isolated and characterized from different species of the genus Alpinia. Some notable are enlisted in Table 1.

Bio-pharmaceutical potential

Reviewing of the genus Alpinia showed its incredible biopharmaceutical potentials as evident from earlier published reports and is gaining the attention of researchers from different disciplines. The presence of the bioactive substances such as flavonoids, tannins and terpenes is the key for its therapeutic efficiency. The potential biomedical applications of diverse species of Alpinia are depicted in Fig. 2. Brief accounts of its biological efficacy towards the therapeutic uses are described below.

Fig. 2.

Fig. 2

Diverse biomedical application of Alpinia species

Antimicrobial activity

A great depth of antimicrobial activities has been reported from Alpinia species having diverse chemical profile. Till date most of the work has been concentrated in A. galanga which contain more bioactive compounds compared to other species in the genera (Janssen and Scheffer 1985; Oonmetta-aree et al. 2006; Khattak et al. 2005; Weerakkody et al. 2011; Rao et al. 2010; Niyomkam et al. 2010). Essential oil extracted from fresh and dried rhizomes of A. galanga have potential antimicrobial activities against a range of bacteria, fungi, yeast and parasite. Ethanol extract from rhizome showed cytological modification to Staphyllococcus aureus cells by altering outer membrane integrity (Oonmetta-aree et al. 2006). However, the galangal extract, being hydrophobic in nature, could not inhibit the proliferation of gram-negative bacteria as the extract unable to penetrate the lipopolysaccharide monolayer of outer membrane of the cell wall. Terpinen-4-ol, a monoterpene, purified from the essential oil of fresh galangal rhizomes, showed antimicrobial activity against Trichophyton mentagrophytes. Similarly, acetoxychavicol acetate (ACA) isolated from dried rhizomes of A. galanga, is potentially active against several bacteria and many dermatophytes (Janssen and Scheffer 1985).

Besides the A. galanga, other species, viz. A. oxyphylla, A. speciosa, A. zerumbet and many others are gaining attention due to the presence of diverse polyphenolic compounds and their complex chemical profile. Various studies showed the antimicrobial potential of crude ethanolic extract, chloroform extract, hydrodistillation extract and a number of purified compounds against a wide spectrum of microorganism (Table 2). Moreover, recent findings showed antiviral potential of diarylheptanoid from A. katsumadai seeds. The extracts showed in vitro neuraminidase inhibitory activities against human influenza virus A/PR/8/34 of subtype H1N1 (Grienke et al. 2010). Further, different fractions of ethanolic extract were found promising against A/Chicken/Korea/MS96/96 (H9N2) influenza viruses operated by inhibiting viral hemagglutinin binding to the sialic acid receptors in the host cell (Kwon et al. 2010). The significant antimicrobial activities of different fractions and pure components of Alpinia species are catalogued in Table 2.

Table 2.

List of antimicrobial, antiparasitic and insecticidal actions of bioactive fractions and pure compounds of Alpinia species

Species name Parts used Bioactive fractions/compounds Bioactivity References
A. galanga Rhizome Acetoxychavicol acetate Antifungal Janssen and Scheffer (1985)
A. katsumadai Seeds Ethanol extract and fractions Antiviral Kwon et al. (2010)
A. conchigera Leaves, stem and rhizomes Essential oil obtained from hydrodistillation Antibacterial and antifungal Ibrahima et al. (2009)
A. galanga Rhizome d,l-1-Acetoxychavicol acetate Antimicrobial Oonmetta-aree et al. (2006)
A. galanga Rhizome Ethanol extract Antimicrobial Khattak et al. (2005)
A. galanga Rhizome Chloroform extract Antigiardial Sawangjaroen et al. (2005)
A. speciosa Leaves Ethanol extract Antimicrobial Wang and Huang (2005)
A. calcarata Rhizome Hydrodistilled essential oil Antifungal Lakshmi et al. (2010)
A. galanga Rhizome Ethanolic extract Antidermatophytic Trakranrungsie et al. (2008)
A. speciosa Leaves 5,6-Dehydrokawain derivatives Antifungal Tawata et al. (1996)
A. ligulata and A. nieuwenhuizii Rhizome Essential oil Antibacterial and antifungal Yusoff et al. (2011)
A. pahangensis Leaves and rhizomes Hydrodistilled essential oil Antibacterial Awang et al. (2011)
A. galanga Rhizome 1′-Acetoxy-chavicol acetate Antibacterial Weerakkody et al. (2011)
A. galanga Leaves and rhizomes Methanol, acetone and diethyl ether extracts Antibacterial Rao et al. (2010)
A. galanga Rhizome Ethyl acetate extract (1′-acetoxychavicol acetate) Protects acne Niyomkam et al. (2010)
A. galanga Rhizome Chloroform extracts Antifungal Phongpaichit et al. (2005)
A. galanga Rhizome Ethanolic extract Antifungal Ficker et al. (2003)
A. galanga Rhizome Chloroform extract Antiamoebic Sawangjaroen et al. (2006)
A. nigra Shoots Crude aqueous extract Flukicidal Roy and Tandon (1999)
A. galanga Rhizome Methanol extract Antimalarial Abdulelah et al. (2010)
A. nigra Shoots Ethanolic extract Anthelmintic Roy and Swargiary (2009)
A. galanga Rhizome Hexane, chloroform and ethyl acetate extract Antileishmanial Kaur et al. (2010)
A. galanga Rhizome Hexane, dichloromethane, ethyl acetate and ethanol Insecticidal Sukhirun et al. (2010)
A. oxyphylla Fruits Methanol extract, yakuchinone A (1) Insecticidal Miyazawa et al. (2001)
A. oxyphylla Fruits Nootkatone Insecticidal Miyazawa et al. (2000)
A. purpurata Flowers Essential oils and aqueous extracts Larvicidal and antibacterial Santos et al. (2012)

Antiparasitic and insecticidal activity

Many parasites and insects pose severe threat to human and animal health. A number of medicinally important plants were tested towards their potential as an antiamoebic agent and it was found that the chloroform extracts from A. galanga to be highly effective with an added desired advantage of less side effects than traditional medicine, viz. metronidazole (Sawangjaroen et al. 2006). Miyazawa et al. (2000) reported that methanolic extract of A. oxyphylla was found to possess insecticidal activity against larvae of Drosophila melanogaster Meigen. From the crude extract, an insecticidal compound was separated by bioassay-guided fractionation and identified to be nootkatone by GC, GC–MS, and 1H and 13C NMR spectroscopy. Further, bioassay-guided studies for insecticidal activity, nootkatone showed a LC50 value of 11.5 μmol/mL of diet against larvae of D. melanogaster and a LD50 value of 96 μg/L against adults. Another compound, epinootkatol, however, showed moderate insecticidal activity in both assays, indicating that the carbonyl group at the 2-position in nootkatone was important for enhanced insecticidal activity (Fig. 3).

Fig. 3.

Fig. 3

The structure of Nootkatone and Epinootkatol isolated from A. oxyphylla fruits, where they differ on their 2-position due to the presence of carbonyl (–C=O) and aldehyde (–CHO) group, respectively

Recently, for the first time antileishmanial phenylpropanoids has been isolated using hexane, chloroform and ethyl acetate extracts of A. galanga rhizome (Kaur et al. 2010). Among several compounds purified, p-coumaryl diacetate, 1′-acetoxychavicol acetate, 1′-acetoxyeugenol acetate and trans-p-acetoxycinnamyl alcohol were found most promising in vitro against promastigotes of L. donovani with IC50 values of 39.3, 32.9, 18.9 and 79.9 μM, respectively. The genus, Alpinia harbour prospective compounds towards the antiparastic and insecticidal actions as enlisted in Table 2.

Anticancerous activity

Many in vitro studies that have been done in diverse cancer cell lines and in vivo studies with animal models reflect clearly the potential of Alpinia species as anticancerous plant. For instance, a novel compound, Pinostrobin chalcone, has been isolated from A. mutica which displays notable cytotoxic potential to various human carcinoma cell lines (KB, MCF7 and Caski cells) with significant IC50 values (Malek et al. 2011). Antiangiogenic potential of A. oxyphylla fruits has been found in n-hexane and ethyl acetate fractions and tested against zebrafish model, human umbilical vein endothelial cells and tumour cell lines and have been hypothesized against cancer and inflammation diseases (He et al. 2010). Investigation of Nam et al. (2005) on the n-hexane and chloroform extract of A. galanga rhizome lead to the isolation of two compounds, viz. 1′-(S)-1′-acetoxychavicol acetate and p-coumaryl alcohol γ-O-methyl ether. Of the two compounds, former showed significant cytotoxic activity against human cancer cell lines like A549 (IC50 = 8.14 μg/mL), SNU638 (IC50 = 1.27 μg/mL), HT1080 (IC50 = 1.2 μg/mL), HL60 (IC50 = 2.39 μg/mL) and HCT116 (IC50 = 1.77 μg/mL). Whereas, the second compound revealed specific activity against SNU638 (IC50 = 1.62 μg/mL). In some other cancer cell lines cytotoxic activity has been screened with four different compounds isolated from A. officinarum and only 7-(3,4-dihydroxyphenyl)-1-(4-hydroxy-3-methoxyphenyl)-4-en-3-heptanone was found remarkable cytotoxic agent against HepG2, MCF-7 and SF-268 (An et al. 2008).

Lu et al. (2007) studied the effect of flavonoid constituents of A. officinarum on whitening effects based on melanin biosynthesis in B 16 mouse melanoma cells. The flavonoid mixture and galangin exhibited a broad absorption band at 270–290 nm related to the UV-B area supporting that galangin could be a whitening agent and a capable candidate for prevention of skin cancer. The summarized anticancerous activities of the crude extract and isolated principal compounds of the genus Alpinia are listed in Table 3.

Table 3.

List of anticancerous, antiinflammatory and analgesic activities showed by bioactive fractions and major compounds from Alpinia species

Species name Parts used Bioactive fractions/compounds Bioactivity References
A. galanga Rhizome 1′S-1′-Acetoxychavicol acetate and p-coumaryl alcohol γ-O-methyl ether Anticancerous Nam et al. (2005)
A. officinarum Rhizome 7-(3,4-Dihydroxyphenyl)-1-(4-hydroxy-3-methoxyphenyl)-4-en-3-heptanone Anticancerous An et al. (2008)
A. pricei Rhizome Ethanolic extract Apoptotic Yang et al. (2008)
A. oxyphylla Fruits Oxyphyllone A and B Anticancerous Xu et al. (2009)
A. conchigera Rhizome 1′S-1′-Acetoxychavicol acetate Apoptotic Awang et al. (2010)
A. katsumadai Seeds Rubraine, isorubraine and sumadain Anticancerous Hua et al. (2009)
A. scabra Leaves and rhizome Hexane and dicholoromethane extract Anticancerous Ibrahim et al. (2010)
A. oxyphylla Fruits Hexane and ethyl acetate fractions Antiangiogenic He et al. (2010)
A. mutica Rhizome Pinostrobin Anticancerous Malek et al. (2011)
A. officinarum Rhizome Galangin Prevents skin cancer Lu et al. (2007)
A. blepharocalyx Seeds Diarylheptanoids Antiproliferative Ali et al. (2001)
A. calcarata Rhizome Aqueous and ethanolic extract Antinociceptive Arambewela et al. (2004)
A. officinarum Rhizome Ethanolic extract Antinociceptive, antiinflammatory, and antipsychiatric Lee et al. (2009)
A. officinarum Rhizome Hydroxy-1,7-diphenyl-4-en-3-heptanone 6, 6-(2-hydroxy-phenyl)-4-methoxy-2-pyrone, 1,7-diphenyl-4-en-3-heptanone, 1,7-diphenyl-5-methoxy-3-heptanone and apigenin Platelet-activating factor (PAF) antagonists Fan et al. (2007)
A. galangal Rhizome Alcoholic and aqueous extracts Antiinflammatory Satish and Dhananjayan (2003)
A. conchigera Rhizome Cardamomin Antiinflammatory Lee et al. (2006)
A. galanga Rhizome 7-(4′-Hydroxy-3′-methoxyphenyl)-1-phenylhept-4-en-3-one Antiinflammatory Yadav et al. (2003)
A. galanga Rhizome 1′S-1′-acetoxychavicol acetate and 1′S-1′-acetoxyeugenol acetate Antiallergic Matsuda et al. (2003a, b)
A. galanga Rhizome Acetoxybenzhydrols Antiallergic Yasuharaa et al. (2009)
A. pricei Rhizome 70 % Ethanolic extract Antiinflammatory Yu et al. (2009)
A. pricei Rhizome Flavokawain B Antiinflammatory Lin et al. (2009)

Antiinflammatory and analgesic activity

Inflammation is a protective response by the organism to eliminate the injurious stimuli and to initiate the healing process. It’s a complex biological response of vascular tissues to detrimental stimuli such as pathogens, injured cells or external irritants (Ferrero-Miliani et al. 2007). Therefore, antiinflammatory drugs refer to the property of a substance that trims down inflammation. Antiinflammatory drugs reduce inflammation without affecting the central nervous system and make up about half of analgesics available in the market. Medication towards inflammation depends on steroids, non-steroidal antiinflammatory drugs (NSAID), immune selective antiinflammatory derivatives (ImSAIDs) and herbal drugs. However, inhibitions of natural hormones and liver dysfunction are the common side effects of steroidal drugs (Urhausen et al. 2003; Hartgens et al. 1996). Similarly, NSAID can cause gastric erosions, leading to stomach ulcers and in extreme cases can cause severe haemorrhage, resulting in death by myocardial infarction and stroke (Trelle et al. 2011). Therefore, ImSAIDs and herbal drugs are more acceptable to treat inflammation and remedying pain. There are several bioactive compounds that have been isolated from Alpinia species which shows antiinflammatory and analgesic actions.

Natural bioactive compounds and crude hydroalcoholic fractions isolated from the Alpinia species like A. galanga, A. zerumbet, A. officinarum, etc., showed potential activities as antiinflammatory and analgesic agent. Aqueous and hydroalcoholic extracts from leaves and rhizomes of above species possesses key factors responsible for antinociceptive (reducing sensitivity to painful stimuli) and antiallergic properties. Diarylheptanoids, a novel class of potent platelet-activating factor (PAF) antagonists from A. officinarum rhizome extract was recently identified (Fan et al. 2007), which also showed antirheumatic, antipsychiatric and analgesic activities with 80 % ethanolic extract (Lee et al. 2009). A brief account of the antiinflammatory, analgesic and other related activities of Alpinia are listed in Table 3.

Neuroprotective activity

A. galanga has been exhaustively explored towards diverse biological activities in most of the cases among different Alpinia species. Recently, chloroform fraction of A. galanga has been found as antiamnesic probably due to the presence of 1′S-1′-acetoxyeuginol acetate as lead compound (Singh et al. 2011a). A. oxyphylla fruit was found to have the neuroprotective activities (Koo et al. 2004) and subsequently many other Alpinia species have been reported since (Table 4). Protocatechuic acid (PCA), a principal compound of the A. oxyphylla, protects against oxidative damage in vitro and reduces oxidative stress in vivo (Shi et al. 2006). It has been shown that PCA also reduces the hydrogen peroxide or sodium nitroprusside induced cell death in PC12 cells in dose-dependent manner (An et al. 2006) and this offers a valuable therapeutic strategy for the cure of oxidative stress-induced neurodegenerative disease like Parkinson’s disease. Other reports revealed that A. katsumadai seed extract protects neurons from ischaemic damage (Li et al. 2011a) and the treatment significantly decreased the activation of astrocytes and microglia in the hippocampal CA1 region (Li et al. 2011b). Similarly, methanolic extract of A. officinarum rhizome showed protection against oxidative damage in PC 12 cells (Chang et al. 2011).

Table 4.

List of neuroprotective and antioxidant activities exhibited by various natural bioactive compounds and crude fractions of Alpinia species

Species name Parts used Bioactive fractions/compounds Bioactivity References
A. oxyphylla Fruits Ethanolic extract Neuroprotective Yu et al. (2003)
A. oxyphylla Fruits Protocatechuic acid Neuroprotective Shi et al. (2006)
A. oxyphylla Kernel Protocatechuic acid Neuroprotective An et al. (2006)
A. officinarum Rhizome Methanolic extract Neuroprotective Chang et al. (2011)
A. katsumadai Seeds 70 % Ethanolic extract Neuroprotective Li et al. (2011a)
A. katsumadai Seeds Ethanolic extract Neuroprotective Li et al. (2011b)
A. oxyphylla Fruits 80 % Ethanolic extract Neuroprotective Zhang et al. (2011b)
A. oxyphylla Fruits Water extract Neuroprotective Koo et al. (2004)
A. oxyphylla Fruits 94 % Ethanolic extract Neuroprotective Yu et al. (2003)
A. galanga Rhizome n-Hexane, chloroform and ethyl acetate Neuroprotective Singh et al. (2011a)
A. galanga Rhizome Ethanolic extract Neuroprotective Singh et al. (2011b)
A. zerumbet Leaves and rhizome Dihydro-5,6-dehydrokawain and other ethyl acetate and hexane extract Antioxidant Elzaawely et al. (2007b)
A. zerumbet Flowers and seeds Ethyl acetate and hexane extract Antioxidant Elzaawely et al. (2007a)
A. galanga and A. allughas Rhizome Dichloromethane and methanol extract Antioxidant Vankar et al. (2006)
A. speciosa Rhizome Feruloyl esters with epicatechin Antioxidant Masuda et al. (2000)
A. katsumadai Seeds Epigallocatechine-3-gallate, resveratrol and total extract Antioxidant Lee et al. (2003)
A. officinarum Rhizome Methanolic extract Antioxidant Chang et al. (2011)
A. calcarata Rhizome Hydrodistilled n-pentane and ether extract Antioxidant Arambewela et al. (2010)
A. oxyphylla Fruits Protocatechuic acid Antioxidant Zhang et al. (2011a)
A. galanga Rhizome Ethanol extract Antioxidant Singh et al. (2011b)
A. densespicata Stem and leaves Ethanol extract Nitric oxide inhibitory Kuo et al. (2009)
A. officinarum Rhizome Hydro alcoholic extract Antioxidant Srividya et al. (2010)

Antioxidant and other activities

Essential oil of A. zerumbet has strong potential as antipsychotic and antioxidant agent (de Araújo et al. 2011) which may have promising efficacy for the treatment of schizophrenia. On the other hand, A. galanga ethanol extract shows antiamnesiac effect in Amyloid β induced neurodegeneration (Singh et al. 2011b). Members of the Alpinia genus are found to have a remarkable antioxidant activity which in turn gives more biological efficacy towards the development of therapeutics. The antioxidant activities of the genus are enlisted in Table 4.

Besides above activities, the genus is also emerging as the prospective source for antiageing compound which is found to be PCA from A. oxyphylla (Zhang et al. 2011a). Aqueous acetone extract of A. officinarum rhizome showed inhibition to melanogenesis process (Matsuda et al. 2009), whereas acetone extract of A. oxyphylla fruits acts as a potent skin permeation enhancer (Fang et al. 2003). Recent studies revealed two bioactive compounds from A. zerumbet rhizome and leaves, viz. 5,6-dehydrokawain (DK) and dihydro-5,6-dehydrokawain (DDK). The compounds were found to be potent inhibitor of HIV-1 integrase and neuraminidase (Upadhyay et al. 2011) indicating that it could be used as potent drugs against those viral diseases.

Future perspective and consideration

In the current study, it has been observed that various plant parts of different Alpinia species are used to get the bioactive compounds and different fractions show remarkable biological efficacy against various biomedical challenges. Detailed examination of the gathered data in Alpinia shows that rhizome is the main plant part used for pharmacological investigation, whereas other vegetative and reproductive parts were used moderately (Fig. 4). Most of the cases it has been observed that rhizomes harbour most of the essential oil components and showed potential biological activities at different scale. It has also been observed that various solvent systems were used in the bioactivity studies and isolation of bioactive compounds from the plant parts which acts as a key factor in terms of yield, number of compounds, type of compounds, etc. In the current study, it has been clearly observed that ethanol fraction has been the most preferred solvent system which has been used either in the initial crude oil extraction or in the further fractionation process (Fig. 5). The aqueous solvent was found to be the second best choice for the study as it also can extract copious amount of essential oil from different plant parts, but it varies from species to species. The bioactive compounds or crude fractions of essential oils from various species of Alpinia were found to be promising against various biomedical challenges like antimicrobial, anticancerous, antileshmania and many more. Also, in the current study, it has been observed that various species of Alpinia has ample potential to overpower biomedical threats including the most diverse microbes in the mother earth. Moreover, the genus Alpinia harbours versatile components towards its diverse biological efficacy (Fig. 6). Much more understanding and further exploration will be needed towards the other unexplored species of the genus, viz. A. nigra, A. katsumadai, A. pahangensis, A. nieuwenhuizii and many more to circumvent the future biomedical challenges.

Fig. 4.

Fig. 4

The graph represents the use of various plant parts in terms of percent use towards the versatile bioactivity studies under consideration in the current review

Fig. 5.

Fig. 5

Different solvent system has been used for the extraction of crude oil and bioactive components. Each bar represents the percentage of uses of each solvent towards the extraction method related to the genus Alpinia documented under current study

Fig. 6.

Fig. 6

The potential application and research carried out in various field of biomedical sciences related to the genus Alpinia and expressed in terms of percentage biological activities considered under the current study

Conclusion

Detailed account of the diverse utility of the genus Alpinia can be addressed, starting with the ethnomedicinal information culminating with exhaustive scientific exploration. Towards the pharmacological investigation and future diagnostics, drug designing and modulating different trans-regulating pathways will be useful to fight against the deadly diseases prevalent in the earth. During the current study, it has been found that the genus possess plenty of flavonoids, tannin and other polyphenolics which extends its biological efficacy towards antiinflammatory, antimicrobial, anticancerous and other therapeutic potentials. It was found in most of the reports and reviews that were surveyed in the present investigation, the crude extract (aqueous or organic fractions) to be potential agent for various activities. However, thorough examination needs to be carried out to see the efficacy and activity of individual component and in combination to explore the synergistic effects, if any.

Acknowledgments

Thanks to Department of Information Technology (DIT), Ministry of Information Technology, Government of India for student fellowship to SG and for research grant to LR (DIT Grant No. DIT No: 0526/T/IITG/014/0809/38).

References

  1. Abdulelah HA, Zurainee MN, Hesham MAM, Mahmud R, Dose ML. Antimalarial activity, phytochemical screening and radical scavenging of methanolic Languas galanga rhizome extract. Molecules. 2010;15:8366–8376. doi: 10.3390/molecules15118366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ali MS, Banskota AH, Tezuka Y, Saiki I, Kadota S. Antiproliferative activity of diarylheptanoids from the seeds of Alpinia blepharocalyx. Biol Pharm Bull. 2001;24(5):525–528. doi: 10.1248/bpb.24.525. [DOI] [PubMed] [Google Scholar]
  3. An LJ, Guan S, Shi GF, Bao YM, Duan YL, Jiang B. Protocatechuic acid from Alpinia oxyphylla against MPP+ -induced neurotoxicity in PC12 cells. Food Chem Toxicol. 2006;44:436–443. doi: 10.1016/j.fct.2005.08.017. [DOI] [PubMed] [Google Scholar]
  4. An N, Zou Z, Tian Z, Luo XZ, Yang S, Xu LZ. Diarylheptanoids from the rhizomes of Alpinia officinarum and their anticancer activity. Fitoterapia. 2008;79:27–31. doi: 10.1016/j.fitote.2007.07.001. [DOI] [PubMed] [Google Scholar]
  5. Arambewela LSR, Arawwawala LDAM, Ratnasooriya WD. Antinociceptive activities of aqueous and ethanolic extracts of Alpinia calcarata rhizomes in rats. J Ethnopharmacol. 2004;95:311–316. doi: 10.1016/j.jep.2004.07.015. [DOI] [PubMed] [Google Scholar]
  6. Arambewela LS, Arawwawala LD, Athauda N. Antioxidant and antifungal activities of essential oil of Alpinia calcarata Roscoe rhizomes. J Ayurveda Integr Med. 2010;1(3):199–202. doi: 10.4103/0975-9476.72621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Awang K, Azmi MN, Aun LIL, Aziz AN, Ibrahim H, Nagoor NH. The apoptotic effect of 1′S-1′-acetoxychavicol acetate from Alpinia conchigera on human cancer cells. Molecules. 2010;15:8048–8059. doi: 10.3390/molecules15118048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Awang K, Ibrahim H, Rosmy Syamsir D, Mohtar M, Mat Ali R, Azah Mohamad Ali N. Chemical constituents and antimicrobial activity of the leaf and rhizome oils of Alpinia pahangensis Ridl., an endemic wild ginger from peninsular Malaysia. Chem Biodivers. 2011;8(4):668–673. doi: 10.1002/cbdv.201000225. [DOI] [PubMed] [Google Scholar]
  9. Chang CL, Lin CS, Lai GH. Phytochemical characteristics, free radical scavenging activities, and neuroprotection of five medicinal plant extracts. Evid Based Complement Alternat Med. 2011 doi: 10.1155/2012/984295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. de Araújo FY, de Oliveira GV, Gomes PX, Soares MA, Silva MI, Carvalho AF, de Moraes MO, de Moraes ME, Vasconcelos SM, Viana GS, de Sousa FC, Macêdo DS. Inhibition of ketamine-induced hyperlocomotion in mice by the essential oil of Alpinia zerumbet: possible involvement of an antioxidant effect. J Pharm Pharmacol. 2011;63(8):1103–1110. doi: 10.1111/j.2042-7158.2011.01312.x. [DOI] [PubMed] [Google Scholar]
  11. Elzaawely AA, Xuan TD, Tawata S. Antioxidant activity and contents of essential oil and phenolic compounds in flowers and seeds of Alpinia zerumbet (Pers.) B.L. Burtt. & R.M. Sm. Food Chem. 2007;104:1648–1653. doi: 10.1016/j.foodchem.2007.03.016. [DOI] [Google Scholar]
  12. Elzaawely AA, Xuan TD, Tawata S. Essential oils, kava pyrones and phenolic compounds from leaves and rhizomes of Alpinia zerumbet (Pers.) B.L. Burtt. & R.M. Sm. and their antioxidant activity. Food Chem. 2007;103:486–494. doi: 10.1016/j.foodchem.2006.08.025. [DOI] [Google Scholar]
  13. Fan G, Kang YH, Han YN, Han BH. Platelet-activating factor (PAF) receptor binding antagonists from Alpinia offcinarum. Bioorg Med Chem Lett. 2007;17:6720–6722. doi: 10.1016/j.bmcl.2007.10.054. [DOI] [PubMed] [Google Scholar]
  14. Fang JY, Leu YL, Hwang TL, Cheng HC, Hung CF. Development of sesquiterpenes from Alpinia oxyphylla as novel skin permeation enhancers. Eur J Pharm Sci. 2003;19:253–262. doi: 10.1016/S0928-0987(03)00118-0. [DOI] [PubMed] [Google Scholar]
  15. Ferrero-Miliani L, Nielsen OH, Andersen PS, Girardin SE. Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol. 2007;147(2):227–235. doi: 10.1111/j.1365-2249.2006.03261.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ficker CE, Smith ML, Susiarti S, Leaman DJ, Irawati C, Arnason JT. Inhibition of human pathogenic fungi by members of Zingiberaceae used by the Kenyah (Indonesian Borneo) J Ethnopharmacol. 2003;85(2–3):289–293. doi: 10.1016/S0378-8741(03)00009-6. [DOI] [PubMed] [Google Scholar]
  17. Ghasi S, Nwobodo E, Ofili JO. Hypocholesterolemic effect of crude leaf of Moringa oleifera in high fat diet fed wistar rats. J Ethnopharmacol. 2000;69:21–25. doi: 10.1016/S0378-8741(99)00106-3. [DOI] [PubMed] [Google Scholar]
  18. Grienke U, Schmidtke M, Kirchmair J, Pfarr K, Wutzler P, Dürrwald R, Wolber G, Liedl KR, Stuppner H, Rollinger JM. Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai. J Med Chem. 2010;53:778–786. doi: 10.1021/jm901440f. [DOI] [PubMed] [Google Scholar]
  19. Hartgens F, Kuipers H, Wijnen JA, Keizer HA. Body composition, cardiovascular risk factors and liver function in long-term androgenic-anabolic steroids using bodybuilders three months after drug withdrawal. Int J Sports Med. 1996;17(6):429–433. doi: 10.1055/s-2007-972873. [DOI] [PubMed] [Google Scholar]
  20. He ZH, Ge W, Yue GGL, Lau CBS, He MF, But PPH. Anti-angiogenic effects of the fruit of Alpinia oxyphylla. J Ethnopharmacol. 2010;132:443–449. doi: 10.1016/j.jep.2010.08.024. [DOI] [PubMed] [Google Scholar]
  21. Hua SZ, Luo JG, Wang XB, Wang JS, Kong LY. Two novel monoterpene–chalcone conjugates isolated from the seeds of Alpinia katsumadai. Bioorg Med Chem Lett. 2009;19:2728–2730. doi: 10.1016/j.bmcl.2009.03.117. [DOI] [PubMed] [Google Scholar]
  22. Ibrahim H, Sim KS, Syamsir DR, Nor NRM, Nurestri AMS, Awang K. Cytotoxic activity of leaf and rhizome extracts of Alpinia scabra (Blume) Náves, a wild ginger from Peninsular Malaysia. Afr J Pharm Pharmacol. 2010;4(10):708–711. [Google Scholar]
  23. Ibrahima H, Aziz AN, Syamsir DR, Ali NAM, Mohtar M, Ali RM, Awang K. Essential oils of Alpinia conchigera Griff. and their antimicrobial activities. Food Chem. 2009;113:575–577. doi: 10.1016/j.foodchem.2008.08.033. [DOI] [Google Scholar]
  24. Jain SK, Prakash V. 22 genera and 178 species in India concentrated mainly in North eastern and the Peninsular region (Zingiberaceae in India) Phytogeography and endemism. Rheedea. 1995;5(2):154–169. [Google Scholar]
  25. Janssen AM, Scheffer JJC. Acetoxychavicol acetate, an antifungal component of Alpinia galanga. Planta Med. 1985;6:507–511. doi: 10.1055/s-2007-969577. [DOI] [PubMed] [Google Scholar]
  26. Kaur A, Singh R, Dey CS, Sharma SS, Bhutani KK, Singh IP. Antileishmanial phenylpropanoids from Alpinia galanga (Linn.) Willd. Ind J Exp Biol. 2010;48:314–317. [PubMed] [Google Scholar]
  27. Khattak S, Rehman S, Shah HU, Ahmad W, Ahmad M. Biological effects of indigenous medicinal plants Curcuma longa and Alpinia galanga. Fitoterapia. 2005;76:254–257. doi: 10.1016/j.fitote.2004.12.012. [DOI] [PubMed] [Google Scholar]
  28. Koo BS, Lee WC, Chang YC, Kim CH. Protective effects of Alpina oxyphylla fructus (Alpinia oxyphylla MIQ) water-extracts on neurons from ischemic damage and neuronal cell toxicity. Phytother Res. 2004;8(2):142–148. doi: 10.1002/ptr.1382. [DOI] [PubMed] [Google Scholar]
  29. Kress WJ, Liu AZ, Newman M, Li QJ. The molecular phylogeny of Alpinia (Zingiberaceae): a complex and polyphyletic genus of gingers. Am J Bot. 2005;92:167–178. doi: 10.3732/ajb.92.1.167. [DOI] [PubMed] [Google Scholar]
  30. Kuo YJ, Hsiao PC, Zhang LJ, Wu MD, Liang YH, Ho HO, Kuo YH. Labdane diterpenoid glycosides from Alpinia densespicata and their nitric oxide inhibitory activities in macrophages. J Nat Prod. 2009;72(6):1097–1101. doi: 10.1021/np900019n. [DOI] [PubMed] [Google Scholar]
  31. Kwon HJ, Kim HH, Yoon SY, Ryu YB, Chang JS, Cho KO, Rho MC, Park SJ, Lee WS. In vitro inhibitory activity of Alpinia katsumadai extracts against influenza virus infection and hemagglutination. Virol J. 2010;7:307. doi: 10.1186/1743-422X-7-307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lakshmi SR, Arambewela LDA, Arawwawala M, Athauda N (2010) Antioxidant and antifungal activities of essential oil of Alpinia calcarata Roscoe rhizomes. J Ayurveda Integr Med 1(3):199–202 [DOI] [PMC free article] [PubMed]
  33. Lee SE, Shin HT, Hwang HJ, Kim JH. Antioxidant activity of extracts from Alpinia katsumadai seed. Phytother Res. 2003;7(9):1041–1047. doi: 10.1002/ptr.1291. [DOI] [PubMed] [Google Scholar]
  34. Lee JH, Jung HS, Giang PM, Jin X, Lee S, Son PT, Lee D, Hong YS, Lee K, Lee JJ. Blockade of nuclear factor-kB signaling pathway and anti-inflammatory activity of Cardamomin, a chalcone analog from Alpinia conchigera. J Pharmacol Exp Ther. 2006;316:271–278. doi: 10.1124/jpet.105.092486. [DOI] [PubMed] [Google Scholar]
  35. Lee JS, Kim KA, Jeong SH, Lee SG, Park HJ, Kim NJ, Lim S. Anti-inflammatory, anti-nociceptive, and anti-psychiatric effects by the rhizomes of Alpinia officinarum on complete Freund’s adjuvant-induced arthritis in rats. J Ethnopharmacol. 2009;126:258–264. doi: 10.1016/j.jep.2009.08.033. [DOI] [PubMed] [Google Scholar]
  36. Li H, Park JH, Yan B, Yoo KY, Lee CH, Choi JH, Hwang IK, Won MH. Neuroprotection of Alpinia katsumadai seed extract against neuronal damage in the ischemic gerbil hippocampus is linked to altered brain-derived neurotrophic factor. Lab Anim Res. 2011;27(1):67–71. doi: 10.5625/lar.2011.27.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Li H, Yoo KY, Lee CH, Choi JH, Hwang IK, Kim JD, Kim YM, Kang IJ, Won MH. Neuroprotective effects of Alpinia katsumadai against neuronal damage in the gerbil hippocampus induced by transient cerebral ischemia. Int J Neurosci. 2011;121(9):490–496. doi: 10.3109/00207454.2011.573111. [DOI] [PubMed] [Google Scholar]
  38. Lin CT, Senthil Kumar KJ, Tseng YH, Wang ZJ, Pan MY, Xiao JH, Chien SC, Wang SY. Anti-inflammatory activity of Flavokawain B from Alpinia pricei Hayata. J Agric Food Chem. 2009;57(14):6060–6065. doi: 10.1021/jf900517d. [DOI] [PubMed] [Google Scholar]
  39. Lu YH, Lin-Tao Wang ZT, Wei DZ, Xiang HB. Mechanism and inhibitory effect of galangin and its flavonoid mixture from Alpinia officinarum on mushroom tyrosinase and B16 murine melanoma cells. J Enzyme Inhib Med Chem. 2007;22(4):433–438. doi: 10.1080/14756360601141562. [DOI] [PubMed] [Google Scholar]
  40. Malek SNA, Phang CW, Ibrahim H, Norhanom AW, Sim KS. Phytochemical and cytotoxic investigations of Alpinia mutica rhizomes. Molecules. 2011;16:583–589. doi: 10.3390/molecules16010583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Masuda T, Mizuguchi S, Tanaka T, Iritani K, Takeda Y. Isolation and structure determination of new antioxidative ferulic acid glucoside esters from the rhizome of Alpinia speciosa, a zingiberaceae plant used in okinawan food culture. J Agric Food Chem. 2000;48(5):1479–1484. doi: 10.1021/jf991294e. [DOI] [PubMed] [Google Scholar]
  42. Matsuda H, Morikawa T, Managi H, Yoshikawa M. Antiallergic principles from Alpinia galanga: structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-alpha and IL-4 in RBL-2H3 cells. Bioorg Med Chem Lett. 2003;13(19):3197–3202. doi: 10.1016/S0960-894X(03)00710-8. [DOI] [PubMed] [Google Scholar]
  43. Matsuda H, Pongpiriyadacha Y, Morikawa T, Ochi M, Yoshikawa M. Gastroprotective effects of phenylpropanoids from the rhizomes of Alpinia galanga in rats: structural requirements and mode of action. Eur J Pharmacol. 2003;471(1):59–67. doi: 10.1016/S0014-2999(03)01785-0. [DOI] [PubMed] [Google Scholar]
  44. Matsuda H, Nakashima S, Oda Y, Nakamura S, Yoshikawa M. Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells. Bioorg Med Chem. 2009;17(16):6048–6053. doi: 10.1016/j.bmc.2009.06.057. [DOI] [PubMed] [Google Scholar]
  45. Miyazawa M, Nakamura Y, Ishikawa Y. Insecticidal sesquiterpene from Alpinia oxyphylla against Drosophila melanogaster. J Agric Food Chem. 2000;48(8):3639–3641. doi: 10.1021/jf000325z. [DOI] [PubMed] [Google Scholar]
  46. Miyazawa M, Nakamura Y, Ishikawa Y. Insecticidal diarylheptanoid from Alpinia oxyphylla against larvae of Drosophila melanogaster. Nat Prod Lett. 2001;15(1):75–79. doi: 10.1080/10575630108041261. [DOI] [PubMed] [Google Scholar]
  47. Nam JW, Kim SJ, Han AR, Lee SK, Seo EK. Cytotoxic phenylpropanoids from rhizomes of Alpinia galanga. J Appl Pharmacol. 2005;13:263–266. [Google Scholar]
  48. Niyomkam P, Kaewbumrung S, Kaewnpparat S, Panichayupakaranant P. Antibacterial activity of Thai herbal extracts on acne involved microorganism. Pharm Biol. 2010;48(4):375–380. doi: 10.3109/13880200903150443. [DOI] [PubMed] [Google Scholar]
  49. Oonmetta-aree J, Suzuki T, Gasaluck P, Eumkeb G. Antimicrobial properties and action of galangal (Alpinia galanga Linn.) on Staphylococcus aureus. LWT Food Sci Technol. 2006;39:1214–1220. doi: 10.1016/j.lwt.2005.06.015. [DOI] [Google Scholar]
  50. Phitak T, Choocheep K, Pothacharoen P, Pompimon W, Premanode B, Kongtawelert P. The effects of p-hydroxycinnamaldehyde from Alpinia galanga extracts on human chondrocytes. Phytochemistry. 2009;70:237–243. doi: 10.1016/j.phytochem.2008.11.010. [DOI] [PubMed] [Google Scholar]
  51. Phongpaichit S, Subhadhirasakul S, Wattanapiromsakul C. Antifungal activities of extracts from Thai medicinal plants against opportunistic fungal pathogens associated with AIDS patients. Mycoses. 2005;48(5):333–338. doi: 10.1111/j.1439-0507.2005.01142.x. [DOI] [PubMed] [Google Scholar]
  52. Prakash V, Mehrotra BN (1995) Zingiberaceae of north-east India: diversity and taxonomic status. In: Proceedings of the 2nd symposium on the family Zingiberaceae, pp 262–273
  53. Pugialli HRL, Kaplan MAC, Gottilieb OR. Chemotaxonomy of superorder Zingiberiflorae (sensu Dahlgren) I. Flavonoids. Acta Bot Bras. 1993;7:135–148. doi: 10.1590/S0102-33061993000200009. [DOI] [Google Scholar]
  54. Rao K, Ch B, Narasu LM, Giri A. Antibacterial activity of Alpinia galanga (L.) Willd crude extracts. Appl Biochem Biotechnol. 2010;162(3):871–884. doi: 10.1007/s12010-009-8900-9. [DOI] [PubMed] [Google Scholar]
  55. Roy B, Swargiary A. Anthelmintic efficacy of ethanolic shoot extract of Alpinia nigra on tegumental enzymes of Fasciolopsis buski, a giant intestinal parasite. J Parasit Dis. 2009;33:48–53. doi: 10.1007/s12639-009-0008-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Roy B, Tandon V. Flukicidal activity of Alpinia nigra against the trematode, Fasciolopsis buski, in humans. Biomed Lett. 1999;60:23–29. [Google Scholar]
  57. Santos GKN, Dutra KA, Barros RA, da Câmara CAG, Lira DD, Gusmão NB, Navarro DMAF. Essential oils from Alpinia purpurata (Zingiberaceae): chemical composition, oviposition deterrence, larvicidal and antibacterial activity. Ind Crops Prod. 2012;40:254–260. doi: 10.1016/j.indcrop.2012.03.020. [DOI] [Google Scholar]
  58. Satish R, Dhananjayan R. Evaluation of anti-inflammatory potential of rhizome of Alpinia galanga Linn. Biomedicine. 2003;23:91–96. [Google Scholar]
  59. Sawangjaroen N, Subhadhirasakul S, Phongpaichit S, Siripanth C, Jamjaroen K, Sawangjaroen K. The in vitro anti-giardial activity of extracts from plants that are used for self-medication by AIDS patients in southern Thailand. Parasitol Res. 2005;95:17–21. doi: 10.1007/s00436-004-1264-8. [DOI] [PubMed] [Google Scholar]
  60. Sawangjaroen N, Phongpaichit S, Subhadhirasakul S, Visutthi M, Srisuwan N, Thammapalerd N. The anti-amoebic activity of some medicinal plants used by AIDS patients in southern Thailand. Parasitol Res. 2006;98:588–592. doi: 10.1007/s00436-005-0119-2. [DOI] [PubMed] [Google Scholar]
  61. Seth SD, Sharma B. Medicinal plants of India. Indian J Med Res. 2004;120:9–11. [PubMed] [Google Scholar]
  62. Shi GF, An LJ, Jiang B, Guan S, Bao YM. Alpinia protocatechuic acid protects against oxidative damage in vitro and reduces oxidative stress in vivo. Neurosci Lett. 2006;403:206–210. doi: 10.1016/j.neulet.2006.02.057. [DOI] [PubMed] [Google Scholar]
  63. Singh HJC, Alagarsamy V, Diwan PV, Kumar SS, Nisha JC, Narsimha Reddy Y (2011a) Neuroprotective effect of Alpinia galanga (L.) fractions on Aβ(25–35) induced amnesia in mice. J Ethnopharmacol. doi:10.1016/j.jep.2011.08.048 [DOI] [PubMed]
  64. Singh HJC, Alagarsamy V, Sathesh Kumar S, Narsimha Reddy Y (2011b) Neurotransmitter metabolic enzymes and antioxidant status on Alzheimer’s disease induced mice treated with Alpinia galanga (L.) Willd. Phytother Res. doi:10.1002/ptr.3364 [DOI] [PubMed]
  65. Srividya AR, Dhanabal SP, Misra VK, Suja G. Antioxidant and antimicrobial activity of Alpinia officinarum. Indian J Pharm Sci. 2010;72(1):145–148. doi: 10.4103/0250-474X.62233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Sukhirun N, Pluempanupat W, Bullangpoti V. Impact of Alpinia galanga rhizome extract on Bactrocera dorsalis population. Commun Agric Appl Biol Sci. 2010;75(3):399–403. [PubMed] [Google Scholar]
  67. Tawata S, Taira S, Kobamoto N, Ishihara M, Toyama S. Syntheses and biological activities of dihydro-5,6-dehydrokawain derivatives. Biosci Biotechnol Biochem. 1996;60(10):1643–1645. doi: 10.1271/bbb.60.1643. [DOI] [PubMed] [Google Scholar]
  68. Trakranrungsie N, Chatchawanchonteera A, Khunkitti W. Ethnoveterinary study for antidermatophytic activity of Piper betle, Alpinia galanga and Allium ascalonicum extracts in vitro. Res Veterinary Sci. 2008;84:80–84. doi: 10.1016/j.rvsc.2007.03.006. [DOI] [PubMed] [Google Scholar]
  69. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011 doi: 10.1136/bmj.c7086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Tushar, Basak S, Sarma GC, Rangan L. Ethnomedical uses of Zingiberaceous plants of Northeast India. J Ethnopharmacol. 2010;132(1):286–296. doi: 10.1016/j.jep.2010.08.032. [DOI] [PubMed] [Google Scholar]
  71. Upadhyay A, Chompoo J, Kishimoto W, Makise T, Tawata S. HIV-1 integrase and neuraminidase inhibitors from Alpinia zerumbet. J Agric Food Chem. 2011;59(7):2857–2862. doi: 10.1021/jf104813k. [DOI] [PubMed] [Google Scholar]
  72. Urhausen A, Torsten A, Wilfried K. Reversibility of the effects on blood cells, lipids, liver function and hormones in former anabolic-androgenic steroid abusers. J Steroid Biochem Mol Biol. 2003;84(2):369–375. doi: 10.1016/S0960-0760(03)00105-5. [DOI] [PubMed] [Google Scholar]
  73. Vankar PS, Tiwari V, Singh LW, Swapana N. Antioxidant properties of some exclusive species of zingiberaceae family of Manipur. J Environ Agric Food Chem. 2006;5:1318–1322. [Google Scholar]
  74. Vanwyk BE, Wink M. Medicinal plant of the world. 1. South Africa: Briz Publication; 2009. [Google Scholar]
  75. Wang YC, Huang TT. Screening of anti-Helicobacter pylori herbs deriving from Taiwanese folk medicinal plants. FEMS Immunol Med Microbiol. 2005;43(2):295–300. doi: 10.1016/j.femsim.2004.09.008. [DOI] [PubMed] [Google Scholar]
  76. Weerakkody NS, Caffin N, Lambert LK, Turner MS, Dykes GA. Synergistic antimicrobial activity of galangal (Alpinia galanga), rosemary (Rosmarinus officinalis) and lemon iron bark (Eucalyptus staigerana) extracts. J Sci Food Agric. 2011;91(3):461–468. doi: 10.1002/jsfa.4206. [DOI] [PubMed] [Google Scholar]
  77. Williams RJ, Spencer JPE, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med. 2004;36(7):838–849. doi: 10.1016/j.freeradbiomed.2004.01.001. [DOI] [PubMed] [Google Scholar]
  78. Wu TL, Larson K. Zingiberaceae. In: Wu Raven., editor. Flora of China. St. Louis: Missouri Botanical Garden Publishing; 2000. pp. 360–363. [Google Scholar]
  79. Xu JJ, Tan NH, Xiong J, Adebayo AH, Han HJ, Zeng GZ, Ji CJ, Zhang YM, Zhu MJ. Oxyphyllones A and B, novel sesquiterpenes with an unusual 4,5-secoeudesmane skeleton from Alpinia oxyphylla. Chin Chem Lett. 2009;20:945–948. doi: 10.1016/j.cclet.2009.03.029. [DOI] [Google Scholar]
  80. Yadav PN, Liu Z, Rafi MMR. A diarylheptanoid from lesser galangal (Alpinia officinarum) inhibits proinflammatory mediators via inhibition of mitogen-activated protein kinase, p44/42, and transcription factor nuclear factor-kappa B. J Pharmacol Exp Ther. 2003;305(3):925–931. doi: 10.1124/jpet.103.049171. [DOI] [PubMed] [Google Scholar]
  81. Yang HL, Chen SC, Chen CS, Wang SY, Hseu YC. Alpinia pricei rhizome extracts induce apoptosis of human carcinoma KB cells via a mitochondria-dependent apoptotic pathway. Food Chem Toxicol. 2008;46:3318–3324. doi: 10.1016/j.fct.2008.08.003. [DOI] [PubMed] [Google Scholar]
  82. Yasuharaa T, Mansea Y, Morimotoa T, Qilongb W, Matsudab H, Yoshikawab M, Muraoka O. Acetoxybenzhydrols as highly active and stable analogues of 1′S-1′-acetoxychavicol, a potent antiallergic principal from Alpinia galanga. Bioorg Med Chem Lett. 2009;19:2944–2946. doi: 10.1016/j.bmcl.2009.04.065. [DOI] [PubMed] [Google Scholar]
  83. Yu X, An L, Wang Y, Zhao H, Gao C. Neuroprotective effect of Alpinia oxyphylla Miq. fruits against glutamate-induced apoptosis in cortical neurons. Toxicol Lett. 2003;144(2):205–212. doi: 10.1016/S0378-4274(03)00219-4. [DOI] [PubMed] [Google Scholar]
  84. Yu YS, Hsu CL, Yen GC. Anti-inflammatory effects of the roots of Alpinia pricei Hayata and its phenolic compounds. J Agric Food Chem. 2009;57(17):7673–7680. doi: 10.1021/jf901327g. [DOI] [PubMed] [Google Scholar]
  85. Yusoff MM, Ibrahim H, Hamid NA. Chemical characterization and antimicrobial activity of rhizome essential oils of very closely allied Zingiberaceae species endemic to Borneo: Alpinia ligulata K. Schum. and Alpinia nieuwenhuizii Val. Chem Biodivers. 2011;8(5):916–923. doi: 10.1002/cbdv.201000270. [DOI] [PubMed] [Google Scholar]
  86. Zhang X, Shi GF, Liu XZ, An LJ, Guan S. Anti-ageing effects of protocatechuic acid from Alpinia on spleen and liver antioxidative system of senescent mice. Cell Biochem Funct. 2011;29(4):342–347. doi: 10.1002/cbf.1757. [DOI] [PubMed] [Google Scholar]
  87. Zhang ZJ, Cheang LC, Wang MW, Li GH, Chu IK, Lin ZX, Lee SM. Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Cell Mol Neurobiol. 2011;32(1):27–40. doi: 10.1007/s10571-011-9731-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from 3 Biotech are provided here courtesy of Springer

RESOURCES